Clinical and Genetic Characteristics of Patients with Early-Onset Diabetes Involving at Least Two Consecutive Generations: Whole-Exome Sequencing in Probands from 25 Pedigrees

Abstract

Background

The molecular mechanisms of early-onset multigenerational diabetes remain unknown. This study aimed to investigate the clinical and genetic characteristics of early-onset diabetes involving at least two consecutive generations.

Methods

From 1296 inpatients with diabetes, we selected individuals who were ≤ 30 years of age and who were clinically suspected of having familial monogenic diabetes. Clinical data were collected from the probands and their family members. Whole-exome sequencing (WES) was used to identify possible causal variants for diabetes. Candidate pathogenic variants were verified by Sanger sequencing, assessed for cosegregation in family members, and evaluated on the basis of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) guidelines. Moreover, missense and synonymous variants were subjected to in silico pathogenicity prediction via MutationTaster and PolyPhen-2. RNAfold was used to predict RNA structural alterations for synonymous variants.

Results

Twenty-five early-onset diabetes patients with a history of familial diabetes were enrolled. Pathogenic/likely pathogenic variants (p.Gly292fs in HNF1A, p.Gly245Argfs*22 in PDX1, p.Asp329His in KCNJ11, p.Leu734Phe and p.Val606Gly in WFS1) were detected in four patients, who were diagnosed accurately and treated with reasonable hypoglycemic agents based on genetic testing results. The variants of uncertain significance (ABCC8 c.3039 G > A (p.Ser1013 = Ser), MAPK8IP1 p.Gln144_Gly145insSerGln, and TBC1D4 p.Arg1249Trp) were identified in three probands.

Conclusion

Patients with early-onset diabetes involving at least two consecutive generations may harbor genetic variants. Genetic testing in this population enables precision diagnosis, informs individualized treatment, and facilitates genetic counseling.

Keywords

Early-onset diabetes / Monogenic diabetes / Genetic testing / Whole-exome sequencing / Pathogenic variants / Pedigree analysis / Precision medicine / Genetic counseling / Medicine

References

[1] SanyouraM, PhilipsonLH, NaylorR. Monogenic Diabetes in Children and Adolescents: Recognition and Treatment Options. Curr Diab Rep., 2018, 18858.

[2] PanJ, JiaW. Early-onset diabetes: an epidemic in China. Front Med., 2018, 12(6): 624-633.

[3] LascarN, BrownJ, PattisonH, et al.. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol., 2018, 6(1): 69-80.

[4] XuY, WangL, HeJ, et al.. Prevalence and control of diabetes in Chinese adults. JAMA., 2013, 310(9): 948-959.

[5] WangL, PengW, ZhaoZ, et al.. Prevalence and Treatment of Diabetes in China, 2013–2018. JAMA, 2021, 326(24): 2498-2506.

[6] ZouX, ZhouX, JiL, et al.. The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional study. Sci Rep., 2017, 746534.

[7] SrinivasanS, ChenL, ToddJ, et al.. The First Genome-Wide Association Study for Type 2 Diabetes in Youth: The Progress in Diabetes Genetics in Youth (ProDiGY) Consortium. Diabetes., 2021, 70(4): 996-1005.

[8] BonnefondA, UnnikrishnanR, DoriaA, et al.. Monogenic diabetes. Nat Rev Dis Primers., 2023, 9112.

[9] VaxillaireM, BonnefondA, LiatisS, et al.. Monogenic diabetes characteristics in a transnational multicenter study from Mediterranean countries. Diabetes Res Clin Pract., 2021, 171108553.

[10] ParkSS, JangSS, AhnCH, et al.. Identifying Pathogenic Variants of Monogenic Diabetes Using Targeted Panel Sequencing in an East Asian Population. J Clin Endocrinol Metab., 2019, 104(9): 4188-4198.

[11] KongX, XingX, ZhangX, et al.. Early-onset type 2 diabetes is associated with genetic variants of β-cell function in the Chinese Han population. Diabetes Metab Res Rev., 2020, 362e3214.

[12] ElSayedNA, AleppoG, ArodaVR, et al.. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care., 2023, 46(Suppl 1): S19-S40.

[13] LiH, DurbinR. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics., 2010, 26(5): 589-595.

[14] RichardsS, AzizN, BaleS, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med., 2015, 17(5): 405-424.

[15] HaddoucheA, Bellanne-ChantelotC, RodA, et al.. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series. J Diabetes., 2020, 12(1): 48-57.

[16] WangX, WangF, WuH, et al.. Detection and analysis of glucose metabolism-related genes in childhood diabetes using targeted next-generation sequencing: In pediatric population-a hospital-based study. Exp Ther Med., 2020, 19(5): 3398-3404

[17] BroomeDT, PantaloneKM, KashyapSR, et al.. Approach to the Patient with MODY-Monogenic Diabetes. J Clin Endocrinol Metab., 2021, 106(1): 237-250.

[18] SousaM, RegoT, ArmasJB. Insights into the Genetics and Signaling Pathways in Maturity-Onset Diabetes of the Young. Int J Mol Sci., 2022, 232112910.

[19] NkongeKM, NkongeDK, NkongeTN. The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY). Clin Diabetes Endocrinol., 2020, 6120.

[20] ValkovicovaT, SkopkovaM, StanikJ, et al.. Novel insights into genetics and clinics of the HNF1A-MODY. Endocr Regul., 2019, 53(2): 110-134.

[21] YounisH, HaSE, JorgensenBG, et al.. Maturity-Onset Diabetes of the Young: Mutations, Physiological Consequences, and Treatment Options. J Pers Med., 2022, 12111762.

[22] HattersleyAT, GreeleySAW, PolakM, et al.. ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes., 2018, 19(Suppl 27): 47-63.

[23] EbrahimN, ShakirovaK, DashinimaevE. PDX1 is the cornerstone of pancreatic β-cell functions and identity. Front Mol Biosci., 2022, 91091757.

[24] MangrumC, RushE, ShivaswamyV. Genetically Targeted Dipeptidyl Peptidase-4 Inhibitor Use in a Patient with a Novel Mutation of MODY type 4. Clin Med Insights Endocrinol Diabetes., 2015, 8: 83-86.

[25] YoshijiS, HorikawaY, KubotaS, et al.. First Japanese Family With PDX1-MODY (MODY4): A Novel PDX1 Frameshift Mutation, Clinical Characteristics, and Implications. J Endocr Soc., 2022, 61bvab159.

[26] FajansSS, BellGI, PazVP, et al.. Obesity and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60. Transl Res., 2010, 156(1): 7-14.

[27] HeB, LiX, ZhouZ. Continuous spectrum of glucose dysmetabolism due to the KCNJ11 gene mutation-Case reports and review of the literature. J Diabetes., 2021, 13(1): 19-32.

[28] RigoliL, AloiC, SalinaA, et al.. Wolfram syndrome 1 in the Italian population: genotype-phenotype correlations. Pediatr Res., 2020, 87(3): 456-462.

[29] PallottaMT, TasciniG, CrispoldiR, et al.. Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives. J Transl Med., 2019, 171238.

[30] RigoliL, CarusoV, SalzanoG, et al.. Wolfram Syndrome 1: From Genetics to Therapy. Int J Environ Res Public Health., 2022, 1963225.

[31] IafuscoD, ZanfardinoA, PiscopoA, et al.. Metabolic Treatment of Wolfram Syndrome. Int J Environ Res Public Health., 2022, 1952755.

[32] KondoM, TanabeK, Amo-ShiinokiK, et al.. Activation of GLP-1 receptor signaling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome. Diabetologia., 2018, 61(10): 2189-2201.

[33] PatchAM, FlanaganSE, BoustredC, et al.. Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period. Diabetes Obes Metab., 2007, 9(Suppl 2): 28-39.

[34] LiM, GongS, HanX, et al.. Genetic variants of ABCC8 and phenotypic features in Chinese early onset diabetes. J Diabetes., 2021, 13(7): 542-553.

[35] WalshIM, BowmanMA, Soto SantarriagaIF, et al.. Synonymous codon substitutions perturb cotranslational protein folding in vivo and impair cell fitness. Proc Natl Acad Sci U S A., 2020, 117(7): 3528-3534.

[36] WaeberG, DelplanqueJ, BonnyC, et al.. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat Genet., 2000, 24(3): 291-295.

[37] SaeedR, MohammedAK, SalehSE, et al.. Expression Silencing of Mitogen-Activated Protein Kinase 8 Interacting Protein-1 Conferred Its Role in Pancreatic β-Cell Physiology and Insulin Secretion. Metabolites., 2023, 132307.

[38] SaeedR, MohammedAK, SalehSE, et al.. Dual Role of Mitogen-Activated Protein Kinase 8 Interacting Protein-1 in Inflammasome and Pancreatic β-Cell Function. Int J Mol Sci., 2023, 2454990.

[39] EickelschulteS, HartwigS, LeiserB, et al.. AKT/AMPK-mediated phosphorylation of TBC1D4 disrupts the interaction with insulin-regulated aminopeptidase. J Biol Chem., 2021, 296100637.

[40] DashS, SanoH, RochfordJJ, et al.. A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia. Proc Natl Acad Sci U S A., 2009, 106(23): 9350-9355.

[41] MoltkeI, GrarupN, JørgensenME, et al.. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature., 2014, 512(7513): 190-193.

[42] CheonCK, LeeYJ, YooS, et al.. Delineation of the genetic and clinical spectrum, including candidate genes, of monogenic diabetes: a multicenter study in South Korea. J Pediatr Endocrinol Metab., 2020, 33(12): 1539-1550.

Funding

Diabetes Talent Research Project of China, International Medical Foundation 2019(No. 2018-N-1)

RIGHTS & PERMISSIONS

The Author(s), under exclusive licence to Huazhong University of Science and Technology